Auto-populated list of related Clinical Trials
(Breast, Cleft Lip and Palate, Hand, Lymphedema, Oral, Skin, Trauma)
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema (massage and elasticsleeve), instituted even before the development of swelling, compared to the use of a newlymarketed device, the Flexitouch®, which electronically simulates the effect of massage uponlymph flow.
Stanford is currently accepting patients for this trial. For more information, please contact Les Roche, RN at 650-724-5913 .
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Flexitouch
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Patients referred to the surgeons of the Stanford University Breast Cancer Program
2. Patients will be required to have the capacity to provide informed consent.
3. All experimental protocols will be reviewed and approved by the Stanford
Institutional Review Board for the Protection of Human Subjects.
4. All of the subjects to be enrolled in the proposed studies will be patients with
unilateral breast cancer who are scheduled to undergo breast surgery and axillary
lymph node dissection, with or without breast conserving techniques.
Exclusion Criteria:
1. Patients with other serious systemic illness (renal failure, hepatic dysfunction,
congestive heart failure, neurological or psychological impairment) that would
confound the study or impair the patients' ability to participate.
2. Patients with recurrent breast cancer or other forms of pre-existing lymphedema will
be ineligible.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Primary Contact:
Les Roche, RN
650-724-5913
Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305